Paranasal sinuses lymphoma and past hepatitis B virus infection: possible association?

Isabel Pinto, Ana Ribeiro, Pedro Valente, Nuno Lima, Diamantino Helena, Artur Condé

Resumen

Lypmphoid neoplasms account for less than 1% of all head and neck cancers. Divided into Hodgkin and non-Hodgkin lymphomas, this last group can be further divided into mature B-cell, mature T-cell and NK/T-cell subtypes.

The authors describe the clinical case of a 64-year-old man with complains of nose blockage. On the physical examination the patient showed a facial and palate swelling. The imaging exams revealed an agressive sinonasal mass with large destruction of the maxillary sinus and hard palate. The biopsy allowed the diagnosis of diffuse large B-cell lymphoma, the most prevalent subtype of B-cell lymphomas.

On the serologic tests was discovered a past hepatitis B virus infection. This information was important for planning the medical treatment but also, because of the possible association between hepatitis B virus infection and increase risk of B-cell lymphoma, particularly diffuse large B-cell lymphoma.

Palabras clave

Paranasal Sinuses; Lymphoma; Large B-Cell; Diffuse; Hepatitis B

Texto completo:

PDF HTML

Referencias

-Wajda BN, Rabinowitz MR, Nyquist GG, Mardekian SK, Rosen MR, Rabinowitz MP. Paranasal sinus lymphoma: Retrospective review with focus on clinical features, histopathology, prognosis, and relationship to systemic lymphoma. Head Neck. 2017;39(6):1065-1070. https://doi.org/10.1002/hed.24686.

-Kim GE et al. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis. Head Neck. 2004;26(7):584-93. https://doi.org/ 10.1002/hed.20015.

-Kanumuri VV, Khan MN, Vazquez A, Govindaraj S, Baredes S, Eloy JA. Diffuse large B-cell lymphoma of the sinonasal tract: analysis of survival in 852 cases. Am J Otolaryngol. 2014;35(2):154-8. https://doi.org/10.1016/j.amjoto.

-Peng KA, Kita AE, Suh JD, Bhuta SM, Wang MB. Sinonasal lymphoma: case series and review of the literature. Int Forum Allergy Rhinol. 2014;4(8):670-4. https://doi.org/10.1002/alr.21337.

-Liang R et al. Treatment outcome and prognostic factors for primary nasal lymphoma.J Clin Oncol. 1995;13(3):666-70. https://doi.org/10.1200/JCO.1995.13.3.666.

-Chen KL et al. Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival. Chin J Cancer. 2015;34(5):225-34. https://doi.org/10.1186/s40880-015-0015-9.

-Wang F et al. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer. 2007;109(7):1360-4. https://doi.org/0.1002/cncr.22549.

-Zhou X, Pan H, Yang P, Ye P, Cao H, Zhou H. Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma. BMC Cancer. 2019;19(1):477. https://doi.org/10.1186/s12885-019-5718-x.

Enlaces refback

  • No hay ningún enlace refback.


Bookmark and Share